BOEHRINGER INGELHEIM EXTENDS SCOPE OF COLLABORATION WITH EVOTEC INTO SCREENING SERVICES

A A

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30) today announced that Boehringer Ingelheim (Boehringer) has extended the scope of its collaboration with Evotec. In addition to the substantial discovery programme to jointly identify and develop therapeutics acting on G-Protein Coupled Receptors (GPCRs) (see press release 8 September 2004) Boehringer research sites in Biberach (Germany) and Laval (Canada) will now collaborate with Evotec under a fee-for-service agreement.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/ca3d108f4f0047f8ce9bd41cdef3d9a8.html)